反应 #335

ord-bddc6734b7ce4143a8ed8f8385933b6e

反应方程式

CCOC(=O)c1cncc(Br)c1
CCOC(=O)c1cncc(Br)c1
C1COCCN1
C1COCCN1
CCOC(=O)c1cncc(N2CCOCC2)c1
CCOC(=O)c1cncc(N2CCO

溶剂

反应条件

温度
80°CELSIUS

实验过程

ethyl 5-bromonicotinate (200 mg, 0.87 mmol), morpholine (0.083 mL, 0.96 mmol), sodium 2-methylpropan-2-olate (167 mg, 1.74 mmol) and 2'-(dicyclohexylphosphino)-N,N-dimethylbiphenyl-2-amine (17.11 mg, 0.04 mmol) were suspended in dioxane (5 mL). The reaction flask was purged with nitrogen and TRIS(DIBENZYLIDENEACETONE)DIPALLADIUM(0) (19.90 mg, 0.02 mmol) was added. The reaction was stirred at 80 °C for 90 minutes. LCMS analysis appeared to indicate addition of 2 morpholine rings and the reaction was abandoned.

来源

750 AstraZeneca ELN dataset